Doctor LIU has engaged in clinical and research work on hematologic diseases for many years, with a Doctor of Medicine from Heidelberg University, Germany.
She specializes in diagnosing and treating various refractory/relapsed hematologic tumors, especially CAR-T cell immunotherapy and related clinical research. Multiple research findings have been published in internationally renowned academic journals such as Blood Cancer Journal, American Journal of Hematology, European Journal of Cancer, and has presented oral presentations at international hematology conferences several times.
